P4-01-18: AP-1 Blockade Potentiates the Anti-Tumor Effect of Endocrine Treatment and Reverts the Resistant Phenotype in Hormone Receptor-Positive Breast Cancer.Livia Malorni, Rachel Schiff, CJ Creighton et al.|Cancer Research|2011Cited by 1
Abstract P6-04-05: GPR110 overexpression increases tumorigenic potential of HER2+ breast cancer cellsMV Trivedi, Rachel Schiff, Raksha R. Bhat et al.|Cancer Research|2013Cited by 0